Expert Medical Council
CLL Society has established an Expert Medical Council which is comprised of a diverse group of world-renowned CLL experts. These trusted individuals work with our medical writers, scientific contributors, and staff to verify that all content is medically accurate, reflects best practices, and conveys the latest evidence-based information.
Syed Ali Abutalib, MD
Co-Director, Hematology and Cellular Therapy Programs
Director, Clinical NMDP and CTCA Apheresis Programs
Cancer Treatment Centers of America, Affiliate of City of Hope
Zion, IL
Farrukh T. Awan, MD
Associate Professor of Internal Medicine
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, TX
Versha Banerji, MD, FRCPC
Senior Scientist & Hematologist, Department of Hematology & Oncology
CancerCare Manitoba
Winnipeg, Manitoba, Canada
Jacqueline C. Barrientos, MD, MS
Chief of Hematologic Malignancies
Director of Oncological Research
Adjunct Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Adjunct Associate Professor, Feinstein Institutes for Medical Research
Mount Sinai Medical Center Comprehensive Cancer Center
Miami Beach, FL
Danielle M. Brander, MD
Division of Hematologic Malignancies & Cellular Therapy
Duke Cancer Institute
Durham, North Carolina
Jennifer R. Brown, MD, PhD
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Director, CLL Center, and Institute Physician
Dana-Farber Cancer Institute
John M. Burke, MD
Associate Chair, US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, CO
John C. Byrd, MD
The Gordon and Helen Hughes Taylor Professor and Chair
Department of Internal Medicine
University of Cincinnati College of Medicine
Cincinnati, OH
Ian Flinn, MD, PhD
Director, Lymphoma Research
Sarah Cannon Center for Blood Cancer
Nashville, TN
Richard R. Furman, MD
Director of the CLL Research Center
Division of Hematology/Oncology
Weill Cornell Medical College
New York, NY
Peter Hillmen, MD, PhD
Professor of Experimental Hematology, Honorary Consultant Hematologist
University of Leeds Teaching Hospitals NHS
Leeds, United Kingdom
Neil Kay, MD
Consultant, Division of Hematology
Mayo Clinic
Rochester, MN
Kaitlin Kennard, BSN, RN
Clinical Research Nurse
Lymphoma Research Program
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, PA
Thomas Kipps, MD, PhD
Professor of Medicine
Division of Hematology-Oncology
Deputy Director of Research
University of California, San Diego Moores Cancer Center
La Jolla, CA
Adam Kittai, MD
Assistant Professor
Division of Hematology
The Ohio State University
Columbus, OH
S. Shahzad Mustafa, MD
Lead Physician – Allergy, Immunology, & Rheumatology
Rochester Regional Health
Clinical Associate Professor of Medicine
University of Rochester School of Medicine and Dentistry
Rochester, NY
Krish Patel, MD
Director, Lymphoma Program
Interim Chief of Hematologic Malignancies and Cellular Therapies
Swedish Cancer Institute
Guilherme Perini, MD
Head of Hematology, Américas Oncologia
Chief of Lymphoma, Hospital Municipal da Vila Santa Catarina
Sao Paulo, Brazil
Tycel J. Phillips, MD
Associate Professor of Medicine
Rogel Cancer Center
University of Michigan
Lindsey Roeker, MD
Medical Oncology/Hematology Fellow
Memorial Sloan Kettering Cancer Center
New York, NY
Steven T. Rosen, MD, FACP
Provost and Chief Scientific Officer
Director, Comprehensive Cancer Center and Beckman Research Institute
City of Hope Comprehensive Cancer Center
Duarte, CA
John Seymour, MBBS, FRACP, PhD
Director, Department of Hematology & Cancer Medicine
Peter MacCallum Cancer Centre
Melbourne, Australia
Mazyar Shadman, MD, MPH
Associate Professor, Division of Medical Oncology
University of Washington School of Medical Oncology
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Seattle, WA
Sanjay Sharma, MD
Hematologist/Oncologist
St. Jude Medical Center
Fullerton, CA
Tanya Siddiqi, MD
Director, Chronic Lymphocytic Leukemia Program, Toni Stephenson Lymphoma Center
Associate Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center
Duarte, CA
Kostas Stamatopoulos, MD, PhD
Director of the Institute of Applied Biosciences
CERTH, Centre for Research and Technology
Hellas, Thessaloniki, Greece
Chris Stewart
Senior Partner
Gallup Inc.
Washington, DC
William G. Wierda, MD, PhD
Clinical Medical Director-Department of Leukemia, Division of Cancer Medicine
Professor, Department of Leukemia, Division of Cancer Medicine
Executive Medical Director, Inpatient Medical Services
The University of Texas MD Anderson Cancer Center
Houston, TX
Adrian Wiestner, MD, PhD
Senior Investigator
Laboratory of Lymphoid Malignancies
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health (NIH)
Bethesda, MD
RECENT NEWS
When appropriate, CLL Society will post updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.
